GlassScriptPhysician profile
Denise M Proctor
NPI 1104163674
$580.37
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $282 · 2023: $16.13 · 2024: $13.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $162.98 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.06 | 2021-2022 | |
| Abbvie INC. | $53.97 | 2021-2022 | |
| Glaxosmithkline, LLC. | $41.17 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Philips North America LLC | $37.58 | 2021-2022 | |
| Amgen INC. | $33.97 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.31 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $28.15 | 2021-2022 | |
| United Therapeutics Corporation | $26.92 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $18.23 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.33 | 2022 | |
| Braeburn INC. | $16.13 | 2023 | Brixadi |
| Smith+Nephew, INC. | $15.74 | 2021 | |
| Genzyme Corporation | $14.25 | 2022 | |
| Eisai INC. | $13.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.